Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Discover which stablecoins pay interest safely and how to assess counterparty risk. This guide helps you compare options and reduce exposure while earning yields.
24,010 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
As Oracle prepares to report its Q4 2026 results, investors are weighing the cloud growth story, AI bets, and margin ...
Investors rally around earnings season, but the big question remains: should abbott labs stock be part of your plan b...
Europe’s move toward UN-led tax dialogue signals a broader shift in global rules. This article breaks down what that ...
As AI infrastructure expands beyond GPUs, investors ask whether Nvidia is undervalued or overvalued — or perhaps both...
SpaceX joining the Nasdaq-100 could reshape how the index moves. This guide breaks down what that means for investors...
As the calendar closes on 2025, Ascendis (ASND) faces the final earnings closeout with questions about cash, pipeline...
A fresh AI-related order sparked a sharp move in Aehr Test Systems stock, with investors pricing in potential growth ...
Retirees are quietly piling into IDV, the iShares International Select Dividend ETF, chasing steady income and intern...
A surge in demand for precision long-range rifles and components is reshaping defense investing. The niche market is ...
SoundHound AI faced a sharp stock move after a major leadership change. This article breaks down what happened, why i...
In uncertain markets, the best consumer staples stocks stand out for their steady demand and reliable dividends. Lear...